Prevalence of anti-SARS-CoV-2 antibodies in people attending the two main Goma markets in the eastern Democratic Republic of the Congo.

Autor: Mitangala PN; Université Catholique de Bukavu, Bukavu, Democratic Republic of Congo.; Université Officielle de Ruwenzori, Butembo, Democratic Republic of Congo., Irenge LM; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain (UCLouvain), Woluwe-Saint-Lambert, Belgium., Musubao ET; Institut de Techniques Médicales, Goma, Democratic Republic of Congo., Kahindo JBM; Université Officielle de Ruwenzori, Butembo, Democratic Republic of Congo., Ayonga PN; Département des maladies infectieuses et tropicales, Université de Bordeaux, Bordeaux, France., Kyembwa Safari I; Inspection Provinciale de la Santé du Nord Kivu, Goma, Democratic Republic of Congo., Kubuya JB; Division Provinciale de la Santé du Nord Kivu, Goma, Democratic Republic of Congo., Ntabe EN; Université Libre des Pays des Grands Lacs, Goma, Democratic Republic of Congo., Kabangwa Senga RK; Laboratoire Provincial Ami Labo Nord Kivu, Goma, Democratic Republic of Congo., Mutombo GN; Division Provinciale de la Santé du Nord Kivu, Goma, Democratic Republic of Congo., Ambroise J; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain (UCLouvain), Woluwe-Saint-Lambert, Belgium., Gala JL; Center for Applied Molecular Technologies, Institute of Clinical and Experimental Research, Université catholique de Louvain (UCLouvain), Woluwe-Saint-Lambert, Belgium.

Publikováno v: Epidemiology and infection [Epidemiol Infect] 2023 Sep 19; Vol. 151, pp. e167. Date of Electronic Publication: 2023 Sep 19.